摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Boc-Phe-Val-NH2 | 33900-19-5

中文名称
——
中文别名
——
英文名称
Boc-Phe-Val-NH2
英文别名
tert-butyl N-[(2S)-1-[[(2S)-1-amino-3-methyl-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate
Boc-Phe-Val-NH2化学式
CAS
33900-19-5
化学式
C19H29N3O4
mdl
——
分子量
363.457
InChiKey
NWULLRLFRDVCFI-GJZGRUSLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.75
  • 重原子数:
    26.0
  • 可旋转键数:
    7.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    110.52
  • 氢给体数:
    3.0
  • 氢受体数:
    4.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Boc-Phe-Val-NH2三氟乙酸 作用下, 反应 1.0h, 以92%的产率得到H-Phe-Val-NH2*HCl
    参考文献:
    名称:
    Opioid Activities of Morphiceptin Analogs Derived from Human β-Casein
    摘要:
    合成了四种含有N端Tyr–Pro序列的四肽酰胺,它们可能是由人β-酪蛋白降解产生的可能与阿片受体结合的物质。当这些肽用于测试它们结合大鼠脑μ和δ阿片受体的能力时,仅H–Tyr–Pro–Phe–Val-NH2有活性,与来自牛β-酪蛋白的吗啡酰肽(H–Tyr–Pro–Phe–Pro–NH2)相比,它对μ受体具有60%的亲和力增加。它也像吗啡酰肽一样具有很高的μ选择性,μ/δ选择性比为285。其他三个类似物,H–Tyr–Pro–Ser–Phe–NH2、H–Tyr–Pro–Val–Arg–NH2 和 H–Tyr–Pro–Val–Pro–NH2,几乎完全无活性。这些结果表明,对于类似吗啡酰肽的四肽酰胺,在第3位存在Phe对于引发与μ阿片受体的结合活性至关重要。通过测量圆二色谱光谱进行的构象分析表明,四肽酰胺序列 Tyr–Pro–Xxx–Pro(或Val)–NH2 是与μ阿片受体相互作用的重要结构要求。
    DOI:
    10.1246/bcsj.63.1753
  • 作为产物:
    描述:
    BOC-L-苯丙氨酸L-缬氨酰胺盐酸盐1-羟基苯并三唑三乙胺N,N'-二环己基碳二亚胺 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以84%的产率得到Boc-Phe-Val-NH2
    参考文献:
    名称:
    Opioid Activities of Morphiceptin Analogs Derived from Human β-Casein
    摘要:
    合成了四种含有N端Tyr–Pro序列的四肽酰胺,它们可能是由人β-酪蛋白降解产生的可能与阿片受体结合的物质。当这些肽用于测试它们结合大鼠脑μ和δ阿片受体的能力时,仅H–Tyr–Pro–Phe–Val-NH2有活性,与来自牛β-酪蛋白的吗啡酰肽(H–Tyr–Pro–Phe–Pro–NH2)相比,它对μ受体具有60%的亲和力增加。它也像吗啡酰肽一样具有很高的μ选择性,μ/δ选择性比为285。其他三个类似物,H–Tyr–Pro–Ser–Phe–NH2、H–Tyr–Pro–Val–Arg–NH2 和 H–Tyr–Pro–Val–Pro–NH2,几乎完全无活性。这些结果表明,对于类似吗啡酰肽的四肽酰胺,在第3位存在Phe对于引发与μ阿片受体的结合活性至关重要。通过测量圆二色谱光谱进行的构象分析表明,四肽酰胺序列 Tyr–Pro–Xxx–Pro(或Val)–NH2 是与μ阿片受体相互作用的重要结构要求。
    DOI:
    10.1246/bcsj.63.1753
点击查看最新优质反应信息

文献信息

  • Polypeptides. Part XII. The preparation of 2-pyridyl esters and their use in peptide synthesis
    作者:A. S. Dutta、J. S. Morley
    DOI:10.1039/j39710002896
    日期:——
    amino-acid derivatives, and hydroxy-compounds) than the corresponding p-nitrophenyl esters. Evidence is presented that they are likely to be particularly useful in solid-phase peptide synthesis, and in the synthesis of O-peptides and depsipeptides.
    2-吡啶基的酯ñ -酰基氨基羧酸可从羧酸,2-羟基吡啶,并准备NN(仅“在吡啶-dicyclohexylcarbodi酰亚胺ñ在乙腈或二氯甲烷中形成-acylureas)。所述Ñ -t丁氧基-羰基-氨基甲酸2-吡啶基酯是大多结晶的,稳定的,并且在非极性溶剂相当对亲核试剂(胺,氨基-酯和酰胺更具反应性的,受阻氨基酸衍生物,和羟基化合物)比相应的对硝基苯酯。证据表明,它们可能在固相肽合成以及O肽和depsipeptide的合成中特别有用。
  • Partially Modified Retro-Inverso Pseudopeptides as Non-natural Ligands for the Human Class I Histocompatibility Molecule HLA-A2
    作者:Gilles Guichard、Francine Connan、Roland Graff、Marina Ostankovitch、Sylviane Muller、Jean-Gérard Guillet、Jeannine Choppin、Jean-Paul Briand
    DOI:10.1021/jm9509511
    日期:1996.1.1
    Syntheses of a series of partially modified retro-inverso analogues of the antigenic peptide M58-66 derived from the influenza virus matrix protein are reported. The retro-inverso modification Psi(NH-CO) was obtained by replacement of two successive amino acid residues with a 2-substituted malonate derivative and gem-diaminoalkyl residue. The resulting compounds 1-8 were tested for their binding to the human histocompatibility class I molecule HLA-A2 in an assembly assay using lysates of peptide transporter-deficient cells T2. Specific peptide-dependent HLA-A2 assembly was revealed by an enzyme-linked immunosorbent assay. Significant HLA-A2 assembly was detected in the presence of analogues [gGly(58)-(S)mLeu(59)]-M58-66 (1a), [gGly(61)-(R,S)mPhe(62)]M58-66 (4), [gVal(63)-(R,S)mPhe(64)]M58-66 (6), and [gPhe(64)-(R,S)mAla(65)]M58-66 (7). The introduction of the retro-inverso modification between P2-P3, P3-P4, P5-P6, and P8-P9 (compounds 2, 3, 5, and 8, respectively) however led to a dramatic reduction in peptide binding to HLA-A2. Interestingly, compound 1a which contains modification between P1-P2 was found to be the most potent analogue, being able to retain the original HLA-A2 binding profile of the parent peptide M58-66. Taken together, these results and recent binding data obtained in the context of murine MHC class I molecule H-2K(d) suggest that the incorporation of peptide bond surrogates in MHC class I-restricted epitopes is a useful approach to design molecules having both increased stability and high MHC-binding capacity. Depending on their agonist or antagonist effects at the T-cell receptor, such non-natural MHC ligands are likely to find many applications in the development of peptide-based vaccines or as potential therapeutic agents in the treatment of allergies and autoimmune diseases.
  • SAKAGUCHI, KAZUYASU;SAKAMOTO, HIROSHI;TSUBAKI, YOSHIKO;WAKI, MICHINORI;CO+, BULL. CHEM. SOC. JAP., 63,(1990) N, C. 1753-1757
    作者:SAKAGUCHI, KAZUYASU、SAKAMOTO, HIROSHI、TSUBAKI, YOSHIKO、WAKI, MICHINORI、CO+
    DOI:——
    日期:——
  • Opioid Activities of Morphiceptin Analogs Derived from Human β-Casein
    作者:Kazuyasu Sakaguchi、Hiroshi Sakamoto、Yoshiko Tsubaki、Michinori Waki、Tommaso Costa、Yasuyuki Shimohigashi
    DOI:10.1246/bcsj.63.1753
    日期:1990.6
    Four tetrapeptide amides with the N-terminal Tyr–Pro sequence were synthesized as possible opioid agonists that can be produced by degradation of human β-casein. When these peptides were tested for their ability to bind to the μ and δ opioid receptors in rat brain, only H–Tyr–Pro–Phe–Val-NH2 was active, showing the 60% increased affinity for the μ receptors as compared with morphiceptin (H–Tyr–Pro–Phe–Pro–NH2) derived from bovine β-casein. It was highly μ-selective, as well as morphiceptin, with the μ/δ-selectivity ratio of 285. Other three analogs, H–Tyr–Pro–Ser–Phe–NH2, H–Tyr–Pro–Val–Arg–NH2 and H–Tyr–Pro–Val–Pro–NH2, were almost completely inactive. These results suggested that, for the morphiceptin-like tetrapeptide amides, the presence of Phe at position 3 is essential to elicit an activity to bind to the μ opioid receptors. Conformational considerations by measuring the CD spectra indicated that the sequence of tetrapeptide amide Tyr–Pro–Xxx–Pro(or Val)–NH2 is an important structural requirement to interact with the μ opioid receptors.
    合成了四种含有N端Tyr–Pro序列的四肽酰胺,它们可能是由人β-酪蛋白降解产生的可能与阿片受体结合的物质。当这些肽用于测试它们结合大鼠脑μ和δ阿片受体的能力时,仅H–Tyr–Pro–Phe–Val-NH2有活性,与来自牛β-酪蛋白的吗啡酰肽(H–Tyr–Pro–Phe–Pro–NH2)相比,它对μ受体具有60%的亲和力增加。它也像吗啡酰肽一样具有很高的μ选择性,μ/δ选择性比为285。其他三个类似物,H–Tyr–Pro–Ser–Phe–NH2、H–Tyr–Pro–Val–Arg–NH2 和 H–Tyr–Pro–Val–Pro–NH2,几乎完全无活性。这些结果表明,对于类似吗啡酰肽的四肽酰胺,在第3位存在Phe对于引发与μ阿片受体的结合活性至关重要。通过测量圆二色谱光谱进行的构象分析表明,四肽酰胺序列 Tyr–Pro–Xxx–Pro(或Val)–NH2 是与μ阿片受体相互作用的重要结构要求。
  • 1,3,5-Triazino Peptide Derivatives: Synthesis, Characterization, and Preliminary Antileishmanial Activity
    作者:Sherine N. Khattab、Hosam H. Khalil、Adnan A. Bekhit、Mohamed M. Abd El-Rahman、Beatriz G. de la Torre、Ayman El-Faham、Fernando Albericio
    DOI:10.1002/cmdc.201700770
    日期:2018.4.6
    All the synthesized peptide derivatives were analyzed by HPLC and fully characterized by IR spectroscopy, 1H and 13C NMR spectroscopy, elemental analysis, and mass spectrometry (MALDI TOF/TOF). A preliminary study of the antileishmanial activity of the 1,3,5‐triazinyl peptide derivatives revealed that four dipeptide amide derivatives showed higher antipromastigote or antiamastigote activity than the
    在溶液中和固相上制备了一个短的二肽,三肽和四肽文库,在N端带有s - triazine部分,在酰胺或乙酯C端都有一个。s-三嗪部分的其余两个位置被甲氧基,吗啉代或哌啶子基取代。所有合成的肽衍生物均通过HPLC进行分析,并通过红外光谱,1 H和13进行了全面表征13 C NMR光谱,元素分析和质谱(MALDI TOF / TOF)。对1,3,5-三嗪基肽衍生物的抗疟原虫活性的初步研究表明,四种二肽酰胺衍生物显示出比参比标准药物miltefosine更高的抗前鞭毛体或抗鞭毛体活性,而没有明显的急性毒性。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物